Today, on 5 July, the Annual Report 2012 and the Corporate Responsibility Report 2012 of the JSC Grindeks were submitted to “Nasdaq OMX Riga”.
Chairman of the Board of JSC Grindeks Juris Bundulis: “Our basic approach is patient-centred and we consider it to be our major success driver. We care about our patients’ health and this gives our business sufficient motivation to be competitive and effective on the global market. The effectiveness of these efforts was proved by our 2012 yearly financial results, reaching the biggest turnover profit figures over the past five years, implementing significant projects in both investments and corporate social responsibility area. More information about the company’s activities is accessible in the Annual Report 2012 and the Corporate Responsibility Report 2012 .”